BRISTOL-MYERS SQUIBB CANADA CO ET AL v. TEVA CANADA LTD ET AL
Summary of A-191-16
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Appeal (S.27 - Final) - Patent Act
Detected Type: Appeal (S.27 - Final) - Patent Act [from T-1364-14 - S. 18.1 Patented Medicines (Notice of Compliance) Regulations]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| BRISTOL MYERS SQUIBB CANADA CO | McCarthy Tétrault LLP | REDDON, ANDREW J |
| BRISTOL MYERS SQUIBB HOLDINGS IRELAND | ||
| MINISTER OF HEALTH (THE) | ||
| NOVARTIS AG | ||
| TEVA CANADA LTD |
| Name | Number |
|---|---|
| 2317736 |
Patented Medicine: Atazanavir (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Bristol-Myers Squibb Canada Co. v. Teva Canada Limited 2017 FCA 76 | Apr 11, 2017 | In proceedings under the PM(NOC) Regulations, the Federal Court (see 2016 FC 580) found that Teva's allegation that the ‘736 patent was invalid for obviousness was justified and dismissed BMS’ application for a writ of prohibition. This is an appeal from that decision. BMS argues that the Federal Court erred in its application of the “obvious to try” test set out in Apotex Inc. v. Sanofi-Synthelabo Canada Inc., 2008 SCC 61 [Plavix 1] and applied by this Court in Sanofi-Aventis v. Apotex Inc., 2013 FCA 186 [Plavix 2]. Specifically, BMS argues that the Federal Court erred in concluding that Teva’s allegation of obviousness was justified in spite of the fact that it found that some of the properties of Type-I atazanavir bisulfate were not predictable before it was made and tested. I come to the same conclusion as the Federal Court though for somewhat different reasons. I would dismiss the appeal. ... In my view, this is the conundrum which the Federal Court faced in this case. Having identified the inventive step as comprising three elements, the Federal Court was forced to say at the conclusion of its analysis that two of those elements were not inventive at all. It is this conclusion which feeds the present appeal. I would say, in light of the Federal Court’s reasoning, that its error was not in its application of the “obvious to try” test but in its identification of the inventive concept. ... On the facts of this case, it seems to me that the facts which support the conclusion that the distance between the prior art and the inventive concept (defined as the solution taught by the patent) could be bridged without recourse to inventiveness would also satisfy the first Lundbeck factor in that it was more or less self-evident that what was being tried ought to work. It seems to me that when this factor is taken it was articulated by the Supreme Court, the conclusion that the Skilled Person would have regarded a salt screen as a more or less self-evident way of getting to a form of atazanavir with greater bioavailability is inescapable. |
This is an appeal from 2016 FC 580 in T-1364-14. [Determination of the appeal is based on automated analysis and should not be relied upon.]
Docket Summary (Google Translate to English)
(41) 2019-03-29 - OttawaTraduction certifiée conforme en français du jugement / doc. # 38 rendu(e)(s) le 11-AVR-2017 déposée le 29-MAR-2019 inscrit(e) dans le livre J. & O., volume 306 page(s) 350 - 350
Modification à la page 13 de la traduction française des motifs du jugement de la cour (le juge Pelletier) rendus le 11 avril 2017 reçu(e)(s) le 15-AOU-2018
Corrections to page(s) 12 24 28 of the Reasons of The Honourable Mr. Justice Pelletier that were dated 11-APR-2017 received on 15-AUG-2018 Corrected pages sent to parties
Traduction certifiée conforme en français des motifs du jugement / doc. # 39 rendu(e)(s) le 11-AVR-2017 déposée le 08-MAI-2018
Letter from the respondent dated 24-MAY-2017 ADVISING THE REGISTRY OF ITS NEW ADDRESS: 20 QUEEN STREET WEST, STE 3300 TOROTNO, ON, M5H 3R3 received on 25-MAY-2017
Acknowledgment of Receipt received from all parties (by email) with respect to the Judgment and Reasons for Judgment dated April 11, 2017 placed on file on 12-APR-2017
Memorandum to file from the Registry of the FCA dated 11-APR-2017 transmitting a copy of the Judgment and Reasons for Judgment to Justice Mactavish and the Applications section of the FC. placed on file.
Reasons for Judgment rendered by The Honourable Mr. Justice Pelletier concurred in by The Honourable Mr. Justice Near The Honourable Mr. Justice Rennie dated 11-APR-2017 The Court's decision is with regard to Appeal Filed on 11-APR-2017
Judgment dated 11-APR-2017 rendered by The Honourable Mr. Justice Pelletier The Honourable Mr. Justice Near The Honourable Mr. Justice Rennie Matter considered with personal appearance The Court's decision is with regard to Appeal Result: dismissed Filed on 11-APR-2017 entered in J. & O. Book, volume 298 page(s) 458 - 458 (Final decision)
Letter from the appellant dated 10-APR-2017 further to the hearing dated 16-JAN-2017, advising that the patent expiry date is 14-APR-2017, when the appeal will befcome moot if a judgment is not rendered. received on 10-APR-2017
Letter from the respondent dated 24-JAN-2017 Request copy of audio recording FCA hearing DARS Z006197 January 16,2017, Toronto. received on 24-JAN-2017
Supplementary Book of Authorities of Teva consisting of 1 volume(s) on behalf of Respondent received on 16-JAN-2017 3 copy(ies) for the Court retained by the local office
Compendium of Respondent,Teva Canada Limited 3 Judges copies 1 registry copy received at hearing on 16-JAN-2017
Supplementary Book of Authorities consisting of 1 volume(s) prepared by the appellant received at hearing on 16-JAN-2017 3 judges' copies retained by the local office
Compendium of Appellants-Construction-Volume 2. 3 Judges copies,one copy for registry received at hearing on 16-JAN-2017
Appellants Compendium-Obviousness-Volume 1 3 Judges copies,1 registry copy received at hearing on 16-JAN-2017
This matter comes on for hearing on 16-JAN-2017 at Toronto before The Honourable Mr. Justice Pelletier The Honourable Mr. Justice Near The Honourable Mr. Justice Rennie Appearances: Mr.Steven G.Mason;Mr.David A. Tait;Mr.Sanjaya Mendis 416-601-8200 for the appellant Mr.Jonathan Stainsby;Mr.Scott Beeser 647-317-6868 for Respondent,Teva Canada Limited No one appearing . for Respondent,Minister of Health Language of Hearing: E Court Usher: John Grise Duration: on 16-JAN-2017 from 09:30 to 01:40 Courtroom : Courtroom No. 7-C - Toronto Court Registrar Jim Outtrim Total duration: 4h10min Before the Court: appeal Result: reserved Comments: Appellant and Respondent submitted Compendium and Supplementary Book of Authorities to the Court at hearing. DARS recording Z006197. Backup recording. Minutes of Hearing entered in Vol. 221 page(s) 39 - 48 Abstract of Hearing placed on file
Letter from the appellant dated 10-JAN-2017 providing a copy of case law for courts' review for the upcoming Appeal hearing, cc to Respondent letter scanned to the panel received on 10-JAN-2017
Solicitor's certificate of service on behalf of Sanjaya Mendis confirming service of doc. 36 upon Respondent by process server on 16-DEC-2016 filed on 16-DEC-2016
Joint Book of Authorities consisting of 3 volume(s) on behalf of Appellant Respondent Filed on 16-DEC-2016 3 copy(ies) for the Court stored in Ottawa
Acknowledgements of receipt of an electronic copy of the order resched uling the hearing to January 16, 2017; e-mail sent to Mr. Reddon (for the Appellants), to Mr. Beeser (for the Respondent, Teva) and to Mr. Peterson (for the Respondent, the Minister) placed on file on 17-NOV-2016
Letter from the Respondent, Teva Canada Limited dated 03-NOV-2016 indicating that due to recent commitments, the hearing date is exceptionally inconvenient to counsel for Teva and respectfully requesting that hearing date be moved to January 16, 2017 received on 03-NOV-2016
Acknowledgements of receipt of an electronic copy of the hearing date order, e-mailed to: Mr. Reddon (for the Appellants), to Mr. Stainsby (for the Respondent, Teva) and to Mr. Peterson (for the Respondent, the Minister) placed on file on 02-NOV-2016
Order (time and place) dated 14-NOV-2016 rendered by S. Bazinet, Judicial Administrator and signed by Judicial Administrator rescheduling Appeal originally to be heard on 10-JAN-2017 now to be heard at Special Sitting in Toronto on 16-JAN-2017 to begin at 09:30 Filed on 14-NOV-2016 cc's sent to parties entered in J. & O. Book, volume 297 page(s) 139 - 139 Transmittal letters placed on file
Order (time and place) dated 01-NOV-2016 rendered by S. Bazinet, Judicial Administrator and signed by Judicial Administrator fixing Appeal to be heard at Special Sitting in Toronto on 10-JAN-2017 to begin at 09:30 Filed on 01-NOV-2016 cc's sent to parties entered in J. & O. Book, volume 297 page(s) 64 - 64 Transmittal letters placed on file
Solicitor's certificate of service on behalf of Jonathan Stainsby confirming service of Doc 32 upon Appellant by personal service on 26-AUG-2016 filed on 26-AUG-2016
Memorandum of fact and law on behalf of the respondent filed on 26-AUG-2016 3 judges' copies stored in Ottawa
Covering letter from Appellants, BMS, dated 12-AUG-2016 concerning the enclosed CD containing the Appellants' Memorandum of Fact and Law placed on file on 15-AUG-2016
Letter from the appellant dated 15-AUG-2016 writing further to the Requisition for Hearing and advising the Court of further dates that the Appellant is not available to attend a hearing, received on 15-AUG-2016
Acknowledgment of Receipt received from all parties (by email) with respect to the Direction of the Court dated August 4, 2016 placed on file on 05-AUG-2016
Revised "CONFIDENTIAL" Appeal Book (Volume 2) consisting of 1 volume(s) prepared by the appellant filed on 28-JUL-2016 3 judges' copies stored in Ottawa
Revised "PUBLIC" Appeal Book Volume 2 consisting of 1 volume(s) prepared by the appellant filed on 28-JUL-2016 3 judges' copies stored in Ottawa
Written directions of the Court: The Honourable Madam Justice Gauthier dated 04-AUG-2016 directing " the Registry is directed to file the revised Appeal Book (Tabs L and M) and to change the covers for Volumes 1 and 3 to 6 of the Appeal Book as described in the appellants' letter dated July 28, 2016." received on 04-AUG-2016
Communication from Registry to Judicial Administrator dated 03-AUG-2016 re: seeking the Court's Direction regarding the Appellant's letter dated July 28, 2016 (ID 34).
Letter from the appellant dated 28-JUL-2016 filing of the Appellants Memorandum of Fact and law and Requisition for hearing. Also the appellant is requesting a number of revisions to the Appeal Book-filed 13-jul-2016 be accepted by the court. received on 28-JUL-2016
Solicitor's certificate of service on behalf of Sanjaya Mendis confirming service of doc. 28-requistion for hearing upon all parties by telecopier on 28-JUL-2016 filed on 28-JUL-2016
Requisition for hearing - Appeal from Appellant filed on 28-JUL-2016
Solicitor's certificate of service on behalf of Sanjaya Mendis confirming service of doc. 26 and revised appeal book(vol2-public & confidential) upon Respondent: Teva & MOH by process server on 27-JUL-2016 filed on 28-JUL-2016
Memorandum of fact and law on behalf of the appellant filed on 28-JUL-2016 3 judges' copies stored in Ottawa
Acknowledgment of Receipt received from solicitors representing all the parties, by email, with respect to document 25. placed on file on 28-JUL-2016
Order dated 27-JUL-2016 rendered by The Honourable Madam Justice Gleason Matter considered without personal appearance The Court's decision is with regard to the motion / document number 8 Result: granted in part "This Court orders that: 1. The appellants shall file a requisition for hearing at the same time as they file their memorandum of fact and law; 2. In addition to the information required by the Rules, the requisition shall accurately list all dates the parties are available between October 1, 2016 and February 28, 2017; [...]" Filed on 28-JUL-2016 entered in J. & O. Book, volume 296 page(s) 17 - 18
Communication from Registry to Judicial Administrator dated 25-JUL-2016 re: A's motion (doc 8).
Solicitor's certificate of service on behalf of Sanjaya Mendis confirming service of doc. #23 upon Respondent by process server on 21-JUL-2016 filed on 21-JUL-2016
Reply Representations on behalf of Appellant in response to the opposing submissions doc. No. 20 to the Motion in writing Filed on 21-JUL-2016
Solicitor's certificate of service on behalf of Jonathan Stainsby confirming service of Doc. 21 and Book of Authorities ID 23 upon all parties by personal service on 15-JUL-2016 filed on 15-JUL-2016
Book of Authorities consisting of 1 volume(s) on behalf of Defendant Teva Canada Limited received on 15-JUL-2016 1 copy(ies) for the Court stored in Ottawa
Motion Record in response to Motion Doc. No. 8 containing the following original document(s): 19 20 Number of copies received: 3 on behalf of Defendant Teva Canada Limited filed on 15-JUL-2016
Written representations contained within a Motion Record on behalf of Respondent Teva Canada Limited in opposition to Doc. 8 filed on 15-JUL-2016
Affidavit of Anna Hucman contained within a Motion Record on behalf of Respondent Teva Canada Limited sworn on 15-JUL-2016 in opposition to Doc. 8 with attached exhibit(s) A filed on 15-JUL-2016
Solicitor's certificate of service on behalf of David Tait confirming service of doc 16,17 upon all parties by process server on 13-JUL-2016 filed on 13-JUL-2016
PUBLIC VERSION of Appeal Book (Volumes 1 2 5) 3 judge's copies stored in Ottawa filed on 13-JUL-2016
Appeal Book consisting of 6 volume(s) including confidential volume(s) 1 2 5 prepared by the appellant filed on 13-JUL-2016 3 judges' copies stored in Ottawa
Solicitor's certificate of service on behalf of Appellant confirming service of doc.14 upon Respondents,Teva Canada, The Minister of Health by telecopier on 08-JUL-2016 filed on 08-JUL-2016
Agreement as to the content of the Appeal book from the appellant filed on 08-JUL-2016
Solicitor's certificate of service on behalf of Sanjaya Mendis confirming service of doc 12 upon Respondents by process server on 06-JUL-2016 filed on 06-JUL-2016
Motion Record containing the following original document(s): 8 9 10 11 Number of copies received: 3 on behalf of Appellant filed on 06-JUL-2016
Written representations contained within a Motion Record on behalf of the appellant in support of doc 8 filed on 06-JUL-2016
Affidavit of Sara Thomas-Dunn contained within a Motion Record on behalf of the appellant sworn on 06-JUL-2016 in support of doc 8 with attached exhibit(s) A-G filed on 06-JUL-2016
Affidavit of Stan North contained within a Motion Record on behalf of the appellant sworn on 05-JUL-2016 in support of doc 8 with attached exhibit(s) A-C filed on 06-JUL-2016
Notice of motion contained within a Motion Record on behalf of the appellant an order fixing the following schedule for this appeal & to schedule the hearing in writing filed on 06-JUL-2016
Copy of doc 1 with proof of service on The Minister of Health-DOJ on 10-JUN-2016 filed on 10-JUN-2016
Affidavit of James Adeney on behalf of the respondent sworn on 13-JUN-2016 confirming service of doc 5 on all parties by telecopier on 13-JUN-2016 filed on 13-JUN-2016
Notice of appearance on behalf of Respondent, Minister of Health filed on 13-JUN-2016
Solicitor's certificate of service on behalf of Jonathan Stainsby confirming service of doc. 3 upon all parties by telecopier on 10-JUN-2016 filed on 10-JUN-2016
Notice of appearance on behalf of Teva Canada Limited filed on 10-JUN-2016
Memorandum to file from the FCA Registry dated 10-JUN-2016 forwarding a copy of the Notice of Appeal to the Applications section of the FC and to the Honourable Justice Mactavish. placed on file.
Affidavit of Heather Van Humbeck on behalf of Applicants sworn on 10-JUN-2016 confirming service of Doc. No. 1 on all parties by telecopier on 10-JUN-2016 filed on 10-JUN-2016
Notice of Appeal filed on 09-JUN-2016 against a decision OF the Honourable Madam Justice Mactavish, dated 27-may-2016 (T-1364-14) Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: